← Back to Search

Procedure

B for Pain

N/A
Waitlist Available
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Symptomatic posterior vitreous detachment with or without vitreoretinal pathology
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up before recruiting patients
Awards & highlights
No Placebo-Only Group

Summary

The scleral depressed exam is an important routine technique for evaluating the retinal periphery for various reasons. During such examination, an instrument is used to bring the anterior part of the retina in the field of view of the physician. The downside of this examination technique is the patient discomfort. Different instruments can be used to do depress the sclera. The objective of our research is to compare three commonly used scleral depressor based on their performance for the ophthalmologist and their subjectively induced discomfort. Patients will be randomly allocated to one of the three examination groups. * Group A: one eye examined with the Schocket scleral depressor, the other eye with the Josephberg-Besser scleral depressor * Group B: one eye examined with the Schocket scleral depressor, the other eye with the cotton tip applicator * Group C: one eye examined with the cotton tip applicator, the other eye with the Josephberg-Besser scleral depressor

Who is the study for?
This trial is for individuals who need a retinal examination, which involves pressing on the eye's surface (sclera) to view the retina. Participants must be comfortable with random assignment to have one of their eyes tested with either a Schocket scleral depressor, Josephberg-Besser scleral depressor, or cotton tip applicator.
What is being tested?
The study aims to compare three tools used in eye exams: Schocket and Josephberg-Besser scleral depressors, and cotton tip applicators. Patients will have different tools used on each eye randomly to determine which causes less discomfort while being effective for the doctor.
What are the potential side effects?
Potential side effects may include discomfort or pain in the eyes during or after using any of these instruments. The severity can vary depending on individual sensitivity and reaction to pressure applied by each tool.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~once, directly after completing the scleral depressed examination, on the same day of inclusion in the study.
This trial's timeline: 3 weeks for screening, Varies for treatment, and once, directly after completing the scleral depressed examination, on the same day of inclusion in the study. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Pain scale
Secondary study objectives
Degree of retinal pathology
Duration of examination
Ergonomics Ease of use
+3 more
Other study objectives
Depressor routinely used by participating physician
Lens routinely used by participating physician

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Active Control
Group I: BActive Control2 Interventions
One eye examined with the Schocket scleral depressor, the other eye with the cotton tip applicator
Group II: AActive Control2 Interventions
One eye examined with the Schocket scleral depressor, the other eye with the Josephberg-Besser scleral depressor
Group III: CActive Control2 Interventions
One eye examined with the cotton tip applicator, the other eye with the Josephberg-Besser scleral depressor

Find a Location

Who is running the clinical trial?

Alberta Retina ConsultantUNKNOWN
1 Previous Clinical Trials
50 Total Patients Enrolled
1 Trials studying Pain
50 Patients Enrolled for Pain
University of AlbertaLead Sponsor
939 Previous Clinical Trials
433,844 Total Patients Enrolled
7 Trials studying Pain
1,693 Patients Enrolled for Pain
University of TorontoOTHER
718 Previous Clinical Trials
1,042,417 Total Patients Enrolled
7 Trials studying Pain
1,151 Patients Enrolled for Pain
~50 spots leftby Apr 2025